PC12 cells express IL-1 receptor type I and response to IL-1beta stimulation

Hai-Feng Shu1, Bai-Ren Wang, Hui Bi

  • 1Institute of Neurosciences, The Fourth Military Medical University, Xi'an 710032, PR China.

Insights

PC12 cells express interleukin-1 receptor type I and respond to IL-1beta. This stimulation inhibits potassium currents, causing membrane depolarization and calcium influx, crucial for neurophysiological studies.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • PC12 cells are a standard model for neurophysiology, including oxygen-sensing research.
  • Interleukin-1 beta (IL-1beta) is a key inflammatory cytokine with known roles in the nervous system.

Purpose of the Study:

  • To investigate the expression of interleukin-1 receptor type I in PC12 cells.
  • To determine the functional effects of IL-1beta on ion channel activity in PC12 cells.

Main Methods:

  • Immunocytochemistry and Western blot to detect receptor expression.
  • Patch-clamp electrophysiology to measure potassium currents (I(K)).
  • Intracellular calcium ([Ca(2+)](i)) imaging.

Main Results:

  • Interleukin-1 receptor type I was confirmed in PC12 cells.
  • IL-1beta dose-dependently inhibited voltage-dependent, TEA-sensitive potassium currents (I(K)).
  • IL-1beta caused membrane depolarization and increased intracellular calcium, effects blocked by an IL-1 receptor antagonist.

Conclusions:

  • PC12 cells possess functional interleukin-1 receptors.
  • IL-1beta modulates ion channel activity in PC12 cells, impacting neuronal excitability.
  • These findings enhance the utility of PC12 cells in studying neuroinflammation and signaling pathways.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...